Literature DB >> 2423828

Place of radioactive iodine in treatment of thyrotoxicosis.

G Hennemann, E P Krenning, K Sankaranarayanan.   

Abstract

The effect of treatment of thyrotoxicosis with drugs, radioactive iodine, or surgery in different age groups is reviewed. In Graves' disease and toxic multinodular goitre the remission rate is about 40-50% after antithyroid drugs, but these drugs have little effect in toxic adenoma. Hypothyroidism developed in 35-49% of patients who had had thyroidectomy, and the risks of operation are high. The risk of malignant disease and genetic abnormalities was not significantly greater after treatment with radioactive iodine in any age group. In general, treatment with radioactive iodine should have priority over thyroidectomy at all ages.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423828     DOI: 10.1016/s0140-6736(86)91675-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Radionuclide therapy for thyroid disease.

Authors:  I R McDougall
Journal:  West J Med       Date:  1992-07

2.  Radioiodine therapy in thyrotoxicosis.

Authors:  M Abu Taher
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

3.  Anaplastic carcinoma of the thyroid following radio-iodine therapy.

Authors:  J Peters; S O'Reilly; J M Barragry
Journal:  Ir J Med Sci       Date:  1993-01       Impact factor: 1.568

Review 4.  Radionuclide therapy of the thyroid.

Authors:  S E Clarke
Journal:  Eur J Nucl Med       Date:  1991

5.  Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.

Authors:  Cihangir Erem; Nurten Kandemir; Arif Hacihasanoglu; Halil Onder Ersöz; Kubilay Ukinc; Mustafa Kocak
Journal:  Endocrine       Date:  2004-10       Impact factor: 3.633

6.  Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria.

Authors:  John Enyi Ejeh M; Karounwi Omotayo Ogunjobi; John Enyi Ejeh; Kayode Solomon Adedapo; Joshua F Eniojukan
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.